Independence Bank of Kentucky’s iShares Biotechnology ETF IBB Stock Holding History

Independence Bank of Kentucky’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.56K	Sell	45 -40	-47%	-$6.88K	﹤0.01%	512
2026 Q1	$14.4K	Hold	85	–	–	﹤0.01%	502
2025 Q4	$14.3K	Hold	85	–	–	﹤0.01%	512
2025 Q3	$12.3K	Sell	85 -15	-15%	-$2.05K	﹤0.01%	522
2025 Q2	$12.7K	Sell	100 -45	-31%	-$5.52K	﹤0.01%	511
2025 Q1	$18.5K	Buy	145 +50	+53%	+$6.78K	﹤0.01%	472
2024 Q4	$12.6K	Hold	95	–	–	﹤0.01%	502
2024 Q3	$13.8K	Hold	95	–	–	﹤0.01%	461
2024 Q2	$13K	Sell	95 -59	-38%	-$7.88K	﹤0.01%	437
2024 Q1	$21.1K	Sell	154 -6	-4%	-$819	0.01%	387
2023 Q4	$21.7K	Sell	160 -50	-24%	-$6.1K	0.01%	368
2023 Q3	$25.7K	Sell	210 -35	-14%	-$4.45K	0.01%	335
2023 Q2	$31.1K	Hold	245	–	–	0.01%	322
2023 Q1	$31.6K	Hold	245	–	–	0.01%	293
2022 Q4	$32K	Hold	245	–	–	0.01%	286
2022 Q3	$29K	Buy	245 +35	+17%	+$4.35K	0.01%	278
2022 Q2	$25K	Buy	210 +115	+121%	+$13.7K	0.01%	298
2022 Q1	$12K	Buy	95 +45	+90%	+$5.86K	﹤0.01%	339
2021 Q4	$8K	Buy	+50	New	+$7.74K	﹤0.01%	348

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Independence Bank of Kentucky's IBB Position: Q2 2026 in Review

Independence Bank of Kentucky reduced its iShares Biotechnology ETF (IBB) stake by 47% in Q2 2026, selling an estimated $6.88K and leaving 45 shares worth $8.56K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Independence Bank of Kentucky first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $32K in Q4 2022. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Independence Bank of Kentucky held 45 shares of iShares Biotechnology ETF worth $8.56K as of Q2 2026.
Independence Bank of Kentucky sold 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
iShares Biotechnology ETF made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #512 holding.
Independence Bank of Kentucky first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
Independence Bank of Kentucky's iShares Biotechnology ETF position peaked at $32K in Q4 2022.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.